Unlock stock picks and a broker-level newsfeed that powers Wall Street.

GSK Sales, Profit Rise on Boost from HIV, Cancer Drugs
GSK Sales, Profit Rise on Boost from HIV, Cancer Drugs · The Wall Street Journal

In This Article:

GSK’s profit rose on better-than-expected performance of HIV, cancer and asthma treatments, offsetting lower vaccine demand in the U.S.